FTSE 100
8.716,45
PKT
-9,56
PKT
-0,11
%
Werbung
Analysen zu FTSE 100-Werten
Datum | Rating | Analyst | |
---|---|---|---|
12.02.15 | Reckitt Benckiser Equal-Weight | Morgan Stanley | |
12.02.15 | Glencore kaufen | Independent Research GmbH | |
12.02.15 | Reckitt Benckiser kaufen | Credit Suisse Group | |
12.02.15 | Reckitt Benckiser neutral | JP Morgan Chase & Co. | |
12.02.15 | Glencore Underweight | JP Morgan Chase & Co. | |
12.02.15 | Glencore Neutral | UBS AG | |
12.02.15 | Reckitt Benckiser buy | Citigroup Corp. | |
12.02.15 | Shell (ex Royal Dutch Shell) buy | Société Générale Group S.A. (SG) | |
12.02.15 | BP Hold | Société Générale Group S.A. (SG) | |
12.02.15 | Unilever Neutral | Goldman Sachs Group Inc. | |
12.02.15 | Unilever Neutral | Goldman Sachs Group Inc. | |
12.02.15 | Reckitt Benckiser buy | Goldman Sachs Group Inc. | |
12.02.15 | Diageo Sell | Goldman Sachs Group Inc. | |
12.02.15 | Reckitt Benckiser verkaufen | Barclays Capital | |
12.02.15 | Reckitt Benckiser buy | Deutsche Bank AG | |
11.02.15 | Reckitt Benckiser Sell | S&P Capital IQ | |
11.02.15 | Glencore Neutral | Goldman Sachs Group Inc. | |
11.02.15 | Rio Tinto Sell | Goldman Sachs Group Inc. | |
11.02.15 | Glencore Reduce | Nomura | |
11.02.15 | BP Neutral | UBS AG | |
10.02.15 | BT Group buy | Nomura | |
10.02.15 | Barclays overweight | Morgan Stanley | |
10.02.15 | AstraZeneca verkaufen | Barclays Capital | |
10.02.15 | Rio Tinto buy | UBS AG | |
10.02.15 | GSK verkaufen | JP Morgan Chase & Co. | |
09.02.15 | GSK Halten | Independent Research GmbH | |
09.02.15 | BT Group buy | Jefferies & Company Inc. | |
09.02.15 | Vodafone Group Halten | Independent Research GmbH | |
09.02.15 | AstraZeneca buy | UBS AG | |
09.02.15 | Rio Tinto overweight | JP Morgan Chase & Co. | |
09.02.15 | Unilever Outperform | Bernstein Research | |
09.02.15 | Unilever Outperform | Bernstein Research | |
09.02.15 | Reckitt Benckiser Outperform | Bernstein Research | |
06.02.15 | Vodafone Group overweight | JP Morgan Chase & Co. | |
06.02.15 | Vodafone Group buy | Citigroup Corp. | |
06.02.15 | Vodafone Group overweight | Morgan Stanley | |
06.02.15 | Prudential Neutral | JP Morgan Chase & Co. | |
06.02.15 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
06.02.15 | Vodafone Group buy | Goldman Sachs Group Inc. | |
06.02.15 | BP Neutral | UBS AG |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.